| 000 | 01899 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513204916.0 | ||
| 264 | 0 | _c20000606 | |
| 008 | 200006s 0 0 eng d | ||
| 022 | _a0959-8049 | ||
| 024 | 7 |
_a10.1016/s0959-8049(99)00315-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aUitterhoeve, A L | |
| 245 | 0 | 0 |
_aToxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer: results of the EORTC 08912 phase I/II study. European Organization for Research and Treatment of Cancer. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _cMar 2000 |
||
| 300 |
_a592-600 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 |
_aCisplatin _xadverse effects |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFeasibility Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aForced Expiratory Volume |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Recurrence, Local |
| 650 | 0 | 4 |
_aRadiotherapy _xadverse effects |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aVital Capacity |
| 700 | 1 | _aBelderbos, J S | |
| 700 | 1 | _aKoolen, M G | |
| 700 | 1 | _avan der Vaart, P J | |
| 700 | 1 | _aRodrigus, P T | |
| 700 | 1 | _aBenraadt, J | |
| 700 | 1 | _aKoning, C C | |
| 700 | 1 | _aGonzález González, D | |
| 700 | 1 | _aBartelink, H | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 36 _gno. 5 _gp. 592-600 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0959-8049(99)00315-9 _zAvailable from publisher's website |
| 999 |
_c10691611 _d10691611 |
||